Skip to Main Content

Paper Details

Outcomes of Children with Inflammatory Bowel Disease who Develop Anti-tumour Necrosis Factor-induced Skin Reactions.
5
2022
Anti-tumour Necrosis Factor, Children, IBD, IFX, Inflammatory Bowel Disease, PD, Skin reactions, UST, adalimumab, alopecia areata, anti-TNF, children, inflammatory bowel disease, infliximab, patients, psoriasiform dermatitis, skin reactions, tumour, tumour necrosis factor
Author NameAffiliation
Marla C DubinskySusan and Leonard Feinstein IBD Clinical Center, Icahn School of Medicine at Mount Sinai
  • 1 - 1

Datasets

Release 1.2